Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Mitchell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Physiology|April 26, 2011
Simulating human cardiac electrophysiology on clinical time-scalesSteven Niederer, Lawrence Mitchell, Nicolas Smith, et al.
Journal of Gastroenterology and Hepatology|January 11, 2011
Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 updateMyron John Tong, Leeyen Hsu, Patrick W Chang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2009
Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigenMyron John Tong, Michael Ong Nguyen, Lori Terese Tong, et al.
Hepatology (Baltimore, Md.)|August 9, 2008
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United StatesMyron John Tong, Carlos Hsien, Leeyen Hsu, et al.
Concurrency and Computation : Practice & Experience|June 3, 2014
Parallel classification and feature selection in microarray data using SPRINTLawrence Mitchell, Terence M Sloan, Muriel Mewissen, et al.
Gastroenterology & Hepatology|April 3, 2014
Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinomaMyron John Tong, Surachate Siripongsakun, Gaelen Stanford-Moore, et al.
Hepatology International|September 10, 2010
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infectionMyron John Tong, Leeyen Hsu, Carlos Hsien, et al.
Digestive Diseases and Sciences|February 27, 2009
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosisMyron John Tong, Carlos Hsien, Joanna Jungeun Song, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Physiology|April 26, 2011
Simulating human cardiac electrophysiology on clinical time-scalesSteven Niederer, Lawrence Mitchell, Nicolas Smith, et al.
Journal of Gastroenterology and Hepatology|January 11, 2011
Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 updateMyron John Tong, Leeyen Hsu, Patrick W Chang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2009
Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigenMyron John Tong, Michael Ong Nguyen, Lori Terese Tong, et al.
Hepatology (Baltimore, Md.)|August 9, 2008
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United StatesMyron John Tong, Carlos Hsien, Leeyen Hsu, et al.
Concurrency and Computation : Practice & Experience|June 3, 2014
Parallel classification and feature selection in microarray data using SPRINTLawrence Mitchell, Terence M Sloan, Muriel Mewissen, et al.
Gastroenterology & Hepatology|April 3, 2014
Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinomaMyron John Tong, Surachate Siripongsakun, Gaelen Stanford-Moore, et al.
Hepatology International|September 10, 2010
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infectionMyron John Tong, Leeyen Hsu, Carlos Hsien, et al.
Digestive Diseases and Sciences|February 27, 2009
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosisMyron John Tong, Carlos Hsien, Joanna Jungeun Song, et al.
Pageof 1